Cure Pharmaceutical Holding Corp. — Form D/A
Cure Pharmaceutical Holding Corp. of OXNARD, CA, a company, filed a Form D amendment with the SEC on 2019-05-29. The offering totals $19.0M, of which $19.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-05-29
- Form: D/A
- Accession: 0001477932-19-003214
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $19.0M
- Amount sold: $19.0M
- Investors: 25
- Date of first sale: 2019-05-14
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-340623
Issuer
- Name: Cure Pharmaceutical Holding Corp.
- CIK: 0001643301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1620 BEACON PLACE, OXNARD, CA, 93033
- Phone: 805-824-0410
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Charles Berman | Director | Oxnard, CA |
| Alan Einstein | Director | Oxnard, CA |
| Alex Katz | Executive Officer | San Francisco, CA |
| Jessica Rousset | Executive Officer | Oxnard, CA |
| Mark Udell | Executive Officer | OXNARD, CA |
| Robert Davidson | Director | OXNARD, CA |
| Robert Davidson | Executive Officer | OXNARD, CA |
| John Bell | Director | New South Wales, C3 |
| Gene Salkind | Director | Shoreham, NY |
| Lauren Chung | Director | New York, NY |
| JOSH HELD | Director | Los Alimitos, CA |
| Anya Goldin | Director | Oxnard, CA |
| Ruben King-Shaw | Director | Oxnard, CA |
| William Yuan | Director | Oxnard, CA |
| Nancy Duitch | Director | Oxnard, CA |
| Mike Redard | Executive Officer | Oxnard, CA |
| EDWARD MALISKI | Executive Officer | OXNARD, CA |
Other filings by this issuer (3)
More